Literature DB >> 11113857

The role of cytochrome P450 in tumour development and progression and its potential in therapy.

G I Murray1.   

Abstract

The cytochromes P450 (P450) are a large group of constitutive and inducible haem-containing enzymes, which have a central role in the oxidative metabolism of a diverse range of xenobiotics. Many P450 substrates are carcinogenic, while other substrates are anti-cancer drugs; the P450s thus have various potentially important roles in tumour biology. Several P450 genes are polymorphic and are associated with the increased risk of cancer development in specific tissues. Individual P450s, especially CYP1B1, are overexpressed in different types of tumours. The increased expression of P450s in tumours is highly significant and is important for understanding tumour development and progression. The tumour-specific expression of P450 provides the basis for the development of novel diagnostic and therapeutic strategies. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11113857     DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH750>3.0.CO;2-0

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  27 in total

1.  Inhibition of cytochrome p450 enzymes by quinones and anthraquinones.

Authors:  Jayalakshmi Sridhar; Jiawang Liu; Maryam Foroozesh; Cheryl L Klein Stevens
Journal:  Chem Res Toxicol       Date:  2012-01-10       Impact factor: 3.739

2.  Chemopreventive effect of piperine on mitochondrial TCA cycle and phase-I and glutathione-metabolizing enzymes in benzo(a)pyrene induced lung carcinogenesis in Swiss albino mice.

Authors:  K Selvendiran; C Thirunavukkarasu; J Prince Vijeya Singh; R Padmavathi; D Sakthisekaran
Journal:  Mol Cell Biochem       Date:  2005-03       Impact factor: 3.396

Review 3.  Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.

Authors:  S Rendic; F P Guengerich
Journal:  Curr Drug Metab       Date:  2010-01       Impact factor: 3.731

4.  CYP3A isoforms in Ewing's sarcoma tumours: an immunohistochemical study with clinical correlation.

Authors:  Hamid Zia; Graeme I Murray; Carrie A Vyhlidal; J Steven Leeder; Ahmed E Anwar; Marilyn M Bui; Atif A Ahmed
Journal:  Int J Exp Pathol       Date:  2015-02-09       Impact factor: 1.925

5.  The role of Ile476 in the structural stability and substrate binding of human cytochrome P450 2C8.

Authors:  Lu Sun; Zhong-Hua Wang; Feng-Yun Ni; Xiang-Shi Tan; Zhong-Xian Huang
Journal:  Protein J       Date:  2010-01       Impact factor: 2.371

6.  Estradiol 17β and its metabolites stimulate cell proliferation and antagonize ascorbic acid-suppressed cell proliferation in human ovarian cancer cells.

Authors:  Hui-Hui Li; Ying-Jie Zhao; Yan Li; Cai-Feng Dai; Sheikh O Jobe; Xing-Sheng Yang; Xing-Fu Li; Manish S Patankar; Ronald R Magness; Jing Zheng
Journal:  Reprod Sci       Date:  2013-06-11       Impact factor: 3.060

7.  20-HETE-producing enzymes are up-regulated in human cancers.

Authors:  Anna Alexanian; Bradley Miller; Richard J Roman; Andrey Sorokin
Journal:  Cancer Genomics Proteomics       Date:  2012 Jul-Aug       Impact factor: 4.069

8.  Antiproliferative effect of the Ginkgo biloba extract is associated with the enhancement of cytochrome P450 1B1 expression in estrogen receptor-negative breast cancer cells.

Authors:  Xiao-Dan Zhao; Ni Dong; Hong-Tao Man; Zhong-Lin Fu; Mei-Hong Zhang; Shuang Kou; Shi-Liang Ma
Journal:  Biomed Rep       Date:  2013-07-22

Review 9.  Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.

Authors:  Robert D Bruno; Vincent C O Njar
Journal:  Bioorg Med Chem       Date:  2007-05-23       Impact factor: 3.641

10.  Ultrafine carbon particles down-regulate CYP1B1 expression in human monocytes.

Authors:  Christiane Eder; Marion Frankenberger; Franz Stanzel; Albrecht Seidel; Karl-Werner Schramm; Loems Ziegler-Heitbrock; Thomas Pj Hofer
Journal:  Part Fibre Toxicol       Date:  2009-10-16       Impact factor: 9.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.